Madrigal Pharmaceuticals Inc (MDGL)
Net Income Growth
-37.03%
Quarterly · Period ending:
MDGL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-37.03%period ending
Latest reported-37.03%period ending
MDGL Quarterly Net Income YoY % (-103.92% → -37.03%)
Year-over-year change
High-resolution chart · PNG
MDGL net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -37.0332% | |
| -28.8825% | |
| 1.4154% | |
| -6.7555% | |
| 72.1782% | |
| 50.3609% | |
| 47.0417% | |
| -8.3289% | |
| -77.1224% | |
| -91.8708% | |
| -30.6024% | |
| -21.6055% | |
| -21.3064% | |
| -33.6903% | |
| -33.0849% | |
| -28.6799% | |
| -14.7264% | |
| -9.4622% | |
| -9.1775% | |
| -8.8626% | |
| -25.7593% | |
| -45.4158% | |
| -113.1327% | |
| -170.4886% | |
| -148.8603% | |
| -139.622% | |
| -141.7429% | |
| -151.7505% | |
| -204.9381% | |
| -136.9579% | |
| -35.8792% | |
| -1.7817% | |
| 22.6069% | |
| -6.0843% | |
| -8.978% | |
| 40.4715% | |
| -190.1286% | |
| 8.0472% | |
| 26.4496% | |
| 20.3044% | |
| 85.4697% | |
| 68.4937% | |
| 48.2311% | |
| 11.7099% | |
| 11.155% | |
| 12.0983% | |
| 15.7686% | |
| 11.3213% | |
| 2.1986% | |
| -13.6482% | |
| -33.3223% | |
| -50.14% | |
| -55.8618% | |
| -37.7184% | |
| -68.6959% | |
| -17.7635% | |
| -16.9413% | |
| -32.0147% | |
| -21.7613% | |
| -24.0889% | |
| -37.7783% | |
| -22.486% | |
| -25.3801% | |
| -108.6878% | |
| -6.8158% | |
| 60.3898% | |
| 72.8856% | |
| 548.7633% | |
| 62.5672% | |
| -33.1388% | |
| -67.1799% | |
| -76.9479% | |
| -35.5594% | |
| -7.9181% | |
| -24.3213% | |
| -6.8069% | |
| -12.145% | |
| -9.5592% | |
| 19.3971% | |
| 47.8116% | |
| 44.0606% | |
| 16.4025% | |
| -103.9169% |